These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12108885

  • 1. Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma.
    Van Schoor J, Joos GF, Pauwels RA.
    Eur Respir J; 2002 Jun; 19(6):997-1002. PubMed ID: 12108885
    [Abstract] [Full Text] [Related]

  • 2. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in neurokinin A airway responsiveness with inhaled lysine-acetylsalicylate in asthma.
    Crimi N, Polosa R, Prosperini G, Magrì S, Ciamarra I, Mistretta A.
    Eur Respir J; 1996 Jun; 9(6):1139-45. PubMed ID: 8804929
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Changes in neurokinin A (NKA) airway responsiveness with inhaled frusemide in asthma.
    Crimi N, Prosperini G, Ciamarra I, Mastruzzo C, Magri S, Polosa R.
    Thorax; 1997 Sep; 52(9):775-9. PubMed ID: 9371207
    [Abstract] [Full Text] [Related]

  • 7. Effects of inhaled steroids on methacholine-induced bronchoconstriction and gas trapping in mild asthma.
    Corsico A, Pellegrino R, Zoia MC, Barbano L, Brusasco V, Cerveri I.
    Eur Respir J; 2000 Apr; 15(4):687-92. PubMed ID: 10780760
    [Abstract] [Full Text] [Related]

  • 8. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 9. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ, Chervinsky P, Wolfe J, Liddle R, Kellerman DJ, Crescenzi KL.
    J Asthma; 1998 Mar; 35(2):153-64. PubMed ID: 9576141
    [Abstract] [Full Text] [Related]

  • 10. Airway responsiveness to adenosine after a single dose of fluticasone propionate discriminates asthma from COPD.
    Spicuzza L, Scuderi V, Morjaria JB, Prosperini G, Arcidiacono G, Caruso M, Folisi C, Di Maria GU, Polosa R.
    Pulm Pharmacol Ther; 2014 Feb; 27(1):70-5. PubMed ID: 23688422
    [Abstract] [Full Text] [Related]

  • 11. Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma.
    Kanniess F, Richter K, Böhme S, Jörres RA, Magnussen H.
    Eur Respir J; 2002 Oct; 20(4):853-8. PubMed ID: 12412675
    [Abstract] [Full Text] [Related]

  • 12. Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma.
    Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'connor BJ.
    J Allergy Clin Immunol; 2002 Oct; 110(4):603-6. PubMed ID: 12373268
    [Abstract] [Full Text] [Related]

  • 13. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
    Boulet LP, Turcotte H, Prince P, Lemière C, Olivenstein R, Laprise C, Larivée P, Bégin P, Laviolette M.
    Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
    [Abstract] [Full Text] [Related]

  • 14. Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction.
    Luijk B, Kempsford RD, Wright AM, Zanen P, Lammers JW.
    Eur Respir J; 2004 Apr; 23(4):559-64. PubMed ID: 15083754
    [Abstract] [Full Text] [Related]

  • 15. The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics.
    Van Schoor J, Joos GF, Chasson BL, Brouard RJ, Pauwels RA.
    Eur Respir J; 1998 Jul; 12(1):17-23. PubMed ID: 9701408
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
    Giannini D, Di Franco A, Bacci E, Dente FL, Taccola M, Vagaggini B, Paggiaro P.
    Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
    [Abstract] [Full Text] [Related]

  • 19. Fifty microg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP.
    Giannini D, Di Franco A, Tonelli M, Bartoli ML, Carnevali S, Cianchetti S, Bacci E, Dente FL, Vagaggini B, Paggiaro PL.
    Respir Med; 2003 May; 97(5):463-7. PubMed ID: 12735661
    [Abstract] [Full Text] [Related]

  • 20. Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma.
    Currie GP, Stenback S, Lipworth BJ.
    Br J Clin Pharmacol; 2003 Jul; 56(1):11-7. PubMed ID: 12848770
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.